- Home
- FENC vs BANX Comparison
FENC vs BANX Comparison
Compare FENC & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- BANX
- Stock Information
- Founded
- FENC 1996
- BANX 2013
- Country
- FENC United States
- BANX United States
- Employees
- FENC N/A
- BANX N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- BANX Trusts Except Educational Religious and Charitable
- Sector
- FENC Health Care
- BANX Finance
- Exchange
- FENC Nasdaq
- BANX Nasdaq
- Market Cap
- FENC 156.9M
- BANX 147.8M
- IPO Year
- FENC 2001
- BANX N/A
- Fundamental
- Price
- FENC $5.54
- BANX $21.18
- Analyst Decision
- FENC Strong Buy
- BANX
- Analyst Count
- FENC 2
- BANX 0
- Target Price
- FENC $14.00
- BANX N/A
- AVG Volume (30 Days)
- FENC 73.5K
- BANX 27.2K
- Earning Date
- FENC 11-07-2024
- BANX 03-05-2025
- Dividend Yield
- FENC N/A
- BANX 9.44%
- EPS Growth
- FENC N/A
- BANX 29.76
- EPS
- FENC N/A
- BANX 2.61
- Revenue
- FENC $49,348,000.00
- BANX $29,948,603.00
- Revenue This Year
- FENC $170.43
- BANX N/A
- Revenue Next Year
- FENC $6.70
- BANX N/A
- P/E Ratio
- FENC N/A
- BANX $8.10
- Revenue Growth
- FENC 278.09
- BANX 18.11
- 52 Week Low
- FENC $3.96
- BANX $17.81
- 52 Week High
- FENC $11.49
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- FENC 40.02
- BANX 57.27
- Support Level
- FENC $5.61
- BANX $20.30
- Resistance Level
- FENC $6.19
- BANX $21.03
- Average True Range (ATR)
- FENC 0.26
- BANX 0.36
- MACD
- FENC -0.10
- BANX -0.01
- Stochastic Oscillator
- FENC 6.42
- BANX 75.21
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds, and others.